Anticancer Drug Chemically Morphed into Antibiotic against Superbug
Unlike current antibiotics, modified anticancer drug interfers with pathways involved in bacterial respiration, and dysregulates protein secretion.
Related Articles
StockWatch: Tools Giants Foresee Revenue Impacts from Tariffs, Job Cuts
Thermo Fisher Scientific and Danaher are projecting that their sales to academic and government (A&G) customers will shrink this year as researchers scramble to adjust…
Assays Improve Gene Therapy Production
One assay applies to bioprocesses that use the HEK293 human embryonic kidney cell line, often used in gene therapy development.
AAV in Action: Setting the Gold Standard in Viral Gene Delivery
On this episode of GEN Live, we’ll talk to experts in delivery with a focus on AAV vectors.
Researchers Test Minimal Helper Plasmids for AAV Production
Scientists have reduced the size of helper plasmids for recombinant adeno-associated viral (rAAV) production.
Bioprinting Technique Brings Vascularized Tissue One Step Closer
Scientists can build microfluidic systems in a Petri dish out of collagen, cells, and other proteins with structural resolution and fidelity.
Signal Alert: Startup Seeks Community Funders for AAV Immuno-Gene Therapy
Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of therapy. Upon FDA approval of an IND application, Siren…
Scaling to New Heights: Using Innovative CHO Media to Support the Efficient Scale-Up of mAb Processes
© 2025 Mary Ann Liebert, Inc. Publishers. All rights reserved.
AACR 2025: Professional Awards Acknowledge Contributions to Cancer Research and Treatment
AACR’s achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.
Sugar Swap Leads to Sweet Spot in Creating “Super Stem Cells”
A small shift in nutrient supply has led to the development of a new method to rejuvenate stem cells.
Novel Leukemia Target Found in RNA-Binding Cell Surface Protein
Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.